Incidence and prevention of infective endocarditis and bacteraemia after transcatheter aortic valve implantation in a French university hospital: a retrospective study

J Hosp Infect. 2018 May;99(1):94-97. doi: 10.1016/j.jhin.2017.11.013. Epub 2017 Nov 28.

Abstract

Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is a rare but severe complication. Among 326 patients who underwent TAVI at Grenoble Alpes University Hospital, six (1.8%) cases of IE and 11 (3.4%) cases of bacteraemia were identified. No cases of IE were linked to the intervention; one was due to Staphylococcus aureus despite a screening and targeted decolonization strategy. This underscores the need for randomized studies to evaluate the benefit and cost-effectiveness of this policy.

Keywords: Bacteraemia; Decolonization; Infective endocarditis; Screening; Staphylococcus aureus; Transcatheter aortic valve implantation.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bacteremia / epidemiology*
  • Endocarditis / complications*
  • Endocarditis / epidemiology*
  • Female
  • France / epidemiology
  • Hospitals, University*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Retrospective Studies
  • Staphylococcal Infections / epidemiology
  • Staphylococcus aureus / isolation & purification
  • Transcatheter Aortic Valve Replacement / adverse effects*